Review the evolution of molecular glues from serendipitous discovery to rational design, highlighting how emerging targets and advances in screening, proteomics, structural biology, and AI are expanding the druggable proteome.
Learning Centers
-
Molecular Glues: Rewiring Protein Interactions for Targeted Degradation -
Restoring Immune Tolerance: New Insights into Autoimmune Disease Research Explore the mechanisms driving immune tolerance breakdown in autoimmune diseases and emerging tolerance-restoring strategies, with a focus on IL-2-based immune modulation. -
Beyond GLP-1: Reprogramming Metabolism Through Next-Generation Therapeutics Explore the evolution from GLP-1 mono-agonists to multi-receptor therapeutics and the expanding role of incretin-based therapies in precision metabolic medicine. -
Beyond Traditional Virtual Screening: New Perspectives on AI-Driven Drug Discovery Explore the limitations of conventional virtual screening, advances in AI-enabled molecular discovery, and their impact on early-stage drug discovery.
